To strengthen the administration and guarantee the quality of imported medicinal materials, on May 16, 2019, the State Administration for Market Regulation (SAMR) issued the revised Measures for ...
Insurers that participate in Medicare’s prescription drug program would be able to exclude certain drugs if prices rise faster than inflation as part of a new proposal from the Trump administration....
Drug launches come with an array of challenges, and GlaxoSmithKline is experiencing that firsthand with its U.S. shingles vaccine rollout. While Shingrix sales are churning ahead of expectations